NYSEARCA:MSOS

Advisorshares Pure Us Cannabis Etf ETF News

etoro logo Buy MSOS
*Your capital is at risk
$4.74
-0.310 (-6.14%)
At Close: Jun 03, 2026
On this week's episode of ETF Prime, host Nate Geraci is joined by VettaFi Head of Research Todd Rosenbluth to discuss hedge funds embracing ETFs, spot ether ETFs, and a potential shortage of ETF tick
Looking at the ETFs with the highest returns YTD, a few thematic standouts have emerged.  As a reminder regarding  long-term investments, thematic investing is cyclical.
The U.S. pot sector could see an influx of medical research funding from healthcare investors amid renewed interest from pharmaceutical firms, should a proposal to reclassify cannabis as a lower-risk
Cannabis may be one of the most controversial investing topics. But, it's also turning out to be one of the most profitable.
There's growing optimism about marijuana reform after news that officials in the U.S. are looking to reschedule the substance. Canadian pot stocks may be the most popular ones to invest in, but multi-
Marijuana ETFs and cannabis stocks shot higher last week after the U.S. Justice Department said it plans to reclassify marijuana as a less dangerous drug.
New reported plans by the U.S. government could pave the pay for profit in marijuana investing. The White House is reportedly seeking to reclassify marijuana from a Schedule I drug to a Schedule III.
Digging into the first quarter's earnings season allows us to uncover the winning themes of the period as captured by ETFs.
The proposed rescheduling of cannabis is the biggest step forward for the industry in decades.

Cannabis ETF (MSOS) Hits New 52-Week High

03:26pm, Friday, 03'rd May 2024
AdvisorShares Pure US Cannabis ETF ( MSOS ) is probably on the radar for investors seeking momentum. The fund just hit a 52-week high and moved up 137.66% from its 52-week low price of $4.78/share.
Hello! This week's ETF Wrap digs into the slump in ETF flows in April and investor positioning around commodities as inflation worries persist.
WASHINGTON — The U.S. Drug Enforcement Administration will move to reclassify marijuana as a less dangerous drug, the Associated Press has learned, a historic shift to generations of American drug p
The US is planning to reclassify cannabis as a less dangerous drug in an historic shift that could have a significant impact across the country.
Pot stocks rally as the DEA moves to reclassify marijuana as a less dangerous drug. Renita Young discusses this as the DEA's proposal needs to be reviewed by the White House Office of Management and B
The stock market sank in the final stretch of April and bond yields climbed on concern that stubborn inflation will force the Federal Reserve to keep interest rates higher for longer. On the eve
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE